YOU ARE HERE:
Side-effects news
page  of 16
 
Headline
Date
  Combining rifampicin with increased doses of lopinavir/ritonavir tablets leads to dangerous increases in liver enzymes
13.05.08
  Does tenofovir increase the risk of efavirenz-associated liver side-effects?
09.05.08
  Insulin resistance may predict risk of cardiovascular disease in HIV
08.05.08
  African-Americans with HIV have higher risk of aggressive kidney disease
07.05.08
  Higher CD4 cell counts associated with lower rate of non-HIV-related diseases in patients taking antiretrovirals
25.04.08
  Reducing d4T dose improves mitochondrial toxicity, but not lipoatrophy
16.04.08
  Abacavir remains an equal first for people starting HIV treatment in US
10.04.08
  Protease inhibitors increase fibrinogen levels: increased risk for hardening of the arteries
08.04.08
  GSK says its abacavir trials show no heart attack risk
02.04.08
  HLA-B*5701 test for abacavir hypersensitivity works equally well in black and white patients
01.04.08
  Start anti-HIV treatment with a CD4 cell count of 350 with efavirenz and Truvada, say draft British guidelines
01.04.08
  Most patients have a trusting relationship with their doctor after starting HIV drugs
31.03.08
  D:A:D finding that abacavir and ddI increase heart attack risk 'incomplete' say FDA
28.03.08
  Immune reconstitution seen in 10% of South Africans starting HIV treatment
26.03.08
  Race and gender risk factors for some anti-HIV treatment side-effects
25.03.08
  Revised US labelling for darunavir/ritonavir recommends caution for patients with liver problems
12.03.08
  Evidence from large US cohort says anti-HIV therapy does not increase heart disease risk
10.03.08
  French study further mystifies causes of bone loss in people with HIV
20.02.08
  Gene associated with efavirenz and nevirapine rash identified
19.02.08
  Key test of kidney function has poor accuracy in patients with HIV
18.02.08

page  of 16